Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

NCT06254157 · tracked via the Priya Life Science USA tracker

Sponsor

Power Life Sciences Inc.

Phase

Observational

Started

2025-03

Last updated

2024-02-12

Condition(s) studied

Generalized Anxiety Disorder

Study summary

Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics.

This study aims to collect extensive data on the clinical trial experiences of individuals with generalized anxiety disorder. The goal is to identify the factors that hinder a patient's enrollment or completion of a trial.

Additionally, the research will examine the data from various demographic perspectives to identify recurring patterns that could offer valuable insights for future generalized anxiety disorder patients.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Confirmed diagnosis of generalized anxiety disorder * Participant must be 18 years of age or older * Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study. Exclusion Criteria: * Pregnant or lactating woman * Participant is actively receiving study therapy in another * Inability to provide written informed consent

Primary outcome measure(s)

Rate of patients who decide to enroll in a generalized anxiety disorder clinical research. — 3 months
Number of generalized anxiety disorder study participants who remain in clinical study until completion. — 12 months

Trial sites (1)

Facility	City	Region	Status
Power Life Sciences	San Francisco	California

More Power Life Sciences Inc. trials in the USA

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research Starting soon

Navigating the Clinical Research Process for Lymphoma Starting soon

Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials Starting soon

Evaluating the Occurrence of Participation Trends Among Weight Loss Clinical Trials Patients Starting soon

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients Starting soon

Other trials for the same condition

RE104 Safety and Efficacy Study in Generalized Anxiety Disorder Recruiting

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder Recruiting

Brain Stimulation & Generalized Anxiety Study Active, not recruiting

Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness Registry Enrolling by invitation

A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06254157 on ClinicalTrials.gov ↗ ← All trials in the USA